Gebelerde grup B streptokok kolonizasyonu ve antimikrobiyal direnç paterni

Bu çalısma grup B streptokokların (GBS) anne ve yenidoğan enfeksiyonlarındaki önemi dikkate alınarak üçüncü trimestr gebelerde GBS kolonizasyon oranını ve antimikrobiyal direnç profilini belirlemek amacıyla yapıldı. Gereç Yöntem: Bu prospektif çalısmada üç aylık süre içinde üçüncü trimestrdeki 112 gebeden vaginal, rektal ve üretral sürüntü örnekleri alındı. Bulgular : Toplam kolonizasyon oranı %8, vaginal kolonizasyon oranı %2.6 olarak saptandı. Hiçbir kökende penisilin, klindamisin, azitromisin, seftriakson, sefazolin, sefotaksim direnci saptanmazken kökenlerin tamamı tetrasikline dirençli bulunmustur. Tartısma : Sonuç olarak hamilelerin GBS tasıyıcılığı yönünden taranması ve antimikrobial direnç paterninin arastırılmasının intrapartum profilaksiye yön vermek açısından önemli olduğunu düsünmekteyiz.

Colonization and antimicrobial resistance patern of group B streptococcus in pregnant women

: The aim of this study was to determine the prevalance of group B streptococcus (GBS) colonization and to evaluate the antimicrobial resistance patern in the third term pregnants in respect to the importance of maternal and neonatal GBS infections. Materials and Methods: In this prospective study over a tree-months period 112 third term pregnant women were screened for GBS colonization. Samples were collected from the vagina, rectum and the urethra. Results: The overall maternal carriage rate was found to be %8 while vaginal colonization rate was %2.6. All of the isolates were sensitive to penicillin, clindamycin, azithromycin, cephazoline, cefotaxime and ceftriaxone whereas all were resistant to tetracycline. Conclusion : In conclusion, screening and evaluation of antimicrobial susceptibility testing of GBS during pregnancy is important to guide appropriate intrapartum prophylaxis.

___

  • 1. Edwards MS, Baker JC. Streptococcus agalactiae (group B streptococcus). Mandell GL, Douglas RC, Bennett JE, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 5inci baskı. Philadelphia: Churchill Livingstone, 2000: 2156-64.
  • 2. Brooks GF, Butel JS, Morse SA. The Streptococci. Jawetz, Melnick, Adelberg eds. Medical Microbiology. 22inci baskı. New York: McGraw Hill, 2001: 203-16.
  • 3. Main EK, Slagle T. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture based protocols. Am J Obstet Gynecol 2000; 182: 1344-7.
  • 4. Gokalp AS, Bakici MZ. Relationship between neonatal group B streptococcal colonization and the maternal urogenital and anorectal system carrier state. Mikrobiyol Bul 1985; 19(2): 65-72.
  • 5. Bilgehan H: Klinik Mikrobiyolojik Tanı. 2nci basım. Đzmir: Safak Matbaacılık, 1995: 507-515.
  • 6. National Committie for Clinical Laboratory Standarts (NCCLS): Performance standarts for antimicrobial suspectibility testing. Ninth informational supplement. NCCLS Document M100-S9, Wayne,Pennsylvania 1999; 19: 1.
  • 7. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol 1991; 77: 604-10.
  • 8. Antony BF, Okada DM, Hobel CJ. Epidemiology of group B streptococcus: longitudinal observations during pregnancy. J Infect Dis 1978; 137: 524-30.
  • 9. Dillon HC Jr, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 1982; 145: 794-9.
  • 10. Meyn LA, Moore DM, Hillier SL, Krohn MA. Association of sexual activity with colonization and vaginal acquisition of group B streptococcus in nonpregnant women. Am J Epidemiol 2002; 155: 949-57.
  • 11. Bolatlı T, Aksit F, Kiraz N. Gebelerde son trimestrde grup B streptokok kolonizasyonu. Türk Mikrobiyol Cemiy Derg 1989; 19: 309-14.
  • 12. Gül HC, Dede M, Avcı ĐY, Eyigün CP, Pahsa A. Üçüncü trimestr Hamilelerde vaginal grup B streptokok kolonizasyonu. Klimik Derg 2005; 18: 27-29.
  • 13. Çelebi S, Tuncel E, Babacan M. Yöremiz gebe kadınlar ve yenidoğanlarda B grubu streptokok prevalansı. Mikrobiol Bül 1992; 26: 149-54.
  • 14. Arısoy AS, Altınısık B, Tünger Ö, Kurutepe S, Đspahi C. Maternal carriage and antimicrobial resistance profile of group B streptococcus. Infection 2003; 31: 244-6.
  • 15. Barbaros I, Murat C, Mehmet V ve ark. The colonization incidence of group B streptococcus in pregnant women and their newborns in Đstanbul. Pediatr Int 2005; 47: 64- 6.
  • 16. Whitney CG, Daly S, Limpongsanurak S ve ark. The international infections in pregnancy study: group B streptococcal colonization in pregnant women. J Matern Fetal Neonatal Med 2004; 15: 267-74.
  • 17. Lim DV, Morales WJ, Walsh AF, Kazanis D. Reduction of morbidity rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol 1986; 23: 489-92.
  • 18. Velaphi S, Siegel JD, Wendel GD Jr, Cushion N, Eid WM, Sanchez PJ. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics 2003; 111: 541-7.
  • 19. Centers for Disease Control and Prevention: Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45 ( RR-7): 1-24.